Logo

FIND

Sequencing-Based Tuberculosis Drug Resistance Testing Gaining Momentum
Premium

The WHO and FIND are supporting NGS-based testing in low-resource settings, while a resistance testing program at New York State's Wadsworth Center has matured.

Cepheid Debuts 10-Color Molecular Detection Technology With New Tuberculosis Test
Premium

The firm launched a CE-IVD marked test for extremely drug-resistant TB and expects to incorporate the multiplexing technology in other assays.

UK Government Invests $28M in FIND to Support SARS-CoV-2 Test Development

FIND will use the funding to support the development of rapid tests, especially in low- and middle-income countries.

Q&A: FIND's Cassandra Kelly-Cirino Discusses COVID-19 Diagnostics Pipelines

The Foundation for Innovative New Diagnostics is tracking commercial coronavirus diagnostics development project, with the goal of guiding procurement.

FIND, WHO Collaborate on Novel Coronavirus MDx Evaluation

The two organizations are collaborating to perform a standardized evaluation of currently available molecular diagnostic tests to assess test performance.

Nov 7, 2019

SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs

Jul 5, 2019

FIND, Unitaid Sign $14.5M Deal to Evaluate NGS-Based Diagnosis of Drug-Resistant TB

Apr 30, 2019

Malaria Test from Eiken Chemical Detects Less-Diagnosed Species
Premium

Sep 19, 2018

India's MolBio Brings Tuberculosis MDx to Point of Care With Help From FIND
Premium

Aug 8, 2018

Genedrive, FIND Partner on HCV Assay Evaluation Study

Aug 30, 2017

Study Highlights Cepheid's Next-Generation TB, Rifampicin Resistance Assay
Premium

Dec 3, 2015

Cepheid, FIND to Evaluate Point-of-Care MDx System, TB Test

Oct 8, 2015

Consortium Seeks to Provide Centralized Access to Global TB Data for Research, Dx Development
Premium

Oct 7, 2015

Paul G. Allen Ebola Program Awards $6.9M for Ebola Diagnostics

Jul 1, 2015

Field Evaluation of Rapid Ebola Immunoassay Reveals Limitations of PCR-Based Testing
Premium

Apr 16, 2015

Cepheid Qualitative HIV-1 Test Receives CE Mark

Mar 19, 2015

Study IDs TB Strains in Swaziland with Drug Resistance Mutations Not Detected by Cepheid Xpert Test
Premium

Dec 29, 2014

Cepheid's HIV MDx Assay Gains CE-IVD Mark

Oct 28, 2014

FIND Collaborates with Multiple Firms on MDx Tests for TB

May 23, 2013

Studies Indicate Effectiveness of New LAMP-based Malaria Test in Modern Labs, Endemic Countries
Premium

Apr 18, 2013

Lumora-FIND Malaria Screening Test May be Tip of Iceberg in MDx Development Partnership
Premium

Apr 17, 2013

Lumora, FIND Partner to Develop High-throughput Malaria Assay

Dec 15, 2011

National U of Singapore, FIND Team on TB Marker Project

Sep 15, 2011

FIND, Eiken Begin Clinical Field Trials for LAMP-Based African Sleeping Sickness Dx
Premium

Feb 3, 2011

In Wake of Q4 Profit, Cepheid Says FIND Will Provide $5M for HIV Viral Load Test
Premium

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.